应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00512 远大医药
未开盘 07-11 16:08:03
9.270
-0.050
-0.54%
最高
9.550
最低
9.180
成交量
1,601万
今开
9.390
昨收
9.320
日振幅
3.97%
总市值
329.05亿
流通市值
329.05亿
总股本
35.50亿
成交额
1.49亿
换手率
0.45%
流通股本
35.50亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
创纪录!远大医药(00512)易甘泰®钇[90Y]15项研究成果入选顶级肝癌会议APPLE ,40万肝癌患者迎新希望
智通财经 · 09:20
创纪录!远大医药(00512)易甘泰®钇[90Y]15项研究成果入选顶级肝癌会议APPLE ,40万肝癌患者迎新希望
晚讯|AI+生物制造风口!9个涉及蛋白质设计案例获国家级认可!FDA获批、国产核药创“全球首个”,能否趁势崛起?
生物谷 · 07-11 11:58
晚讯|AI+生物制造风口!9个涉及蛋白质设计案例获国家级认可!FDA获批、国产核药创“全球首个”,能否趁势崛起?
每日卖空追踪 | 远大医药 07月11日卖空量成交49.75万股,卖空比例为3.11%
市场透视 · 07-11 08:30
每日卖空追踪 | 远大医药 07月11日卖空量成交49.75万股,卖空比例为3.11%
远大医药07月11日遭主力抛售179.1万元
市场透视 · 07-11 08:15
远大医药07月11日遭主力抛售179.1万元
远大医药07月10日主力净流出486.6万元 散户资金买入
市场透视 · 07-10
远大医药07月10日主力净流出486.6万元 散户资金买入
每日卖空追踪 | 远大医药 07月09日卖空量成交243万股,卖空比例为13.69%
市场透视 · 07-09
每日卖空追踪 | 远大医药 07月09日卖空量成交243万股,卖空比例为13.69%
远大医药07月09日获主力加仓610.7万元
市场透视 · 07-09
远大医药07月09日获主力加仓610.7万元
FDA提前批准!远大医药核药再创全球首个
瞪羚社 · 07-08
FDA提前批准!远大医药核药再创全球首个
创新药概念股多数走强 恒瑞医药(01276)涨3.37% 机构称创新药产业投资趋势明确
金吾财讯 · 07-08
创新药概念股多数走强 恒瑞医药(01276)涨3.37% 机构称创新药产业投资趋势明确
远大医药:高开5.5%,易甘泰获FDA提前批准新适应症
和讯网 · 07-08
远大医药:高开5.5%,易甘泰获FDA提前批准新适应症
港股异动 | 远大医药(00512)高开逾5% 易甘泰获FDA提前正式批准新增HCC适应症
智通财经 · 07-08
港股异动 | 远大医药(00512)高开逾5% 易甘泰获FDA提前正式批准新增HCC适应症
全球核药龙头大消息
中国基金报 · 07-07
全球核药龙头大消息
远大医药(00512)易甘泰®海外临床取得突破性中期数据,获FDA提前正式批准拓展HCC适应症,或重塑肝癌治疗格局
智通财经 · 07-07
远大医药(00512)易甘泰®海外临床取得突破性中期数据,获FDA提前正式批准拓展HCC适应症,或重塑肝癌治疗格局
远大医药(00512.HK):集团全球创新放射性产品SIR-Spheres®钇[90Y]微球注射液提前正式获得FDA批准新增适应症
格隆汇 · 07-07
远大医药(00512.HK):集团全球创新放射性产品SIR-Spheres®钇[90Y]微球注射液提前正式获得FDA批准新增适应症
每日卖空追踪 | 远大医药 07月07日卖空量成交125.1万股,卖空比例为10.22%
市场透视 · 07-07
每日卖空追踪 | 远大医药 07月07日卖空量成交125.1万股,卖空比例为10.22%
远大医药07月07日主力净流出24.2万元 散户资金买入
市场透视 · 07-07
远大医药07月07日主力净流出24.2万元 散户资金买入
每日卖空追踪 | 远大医药 07月04日卖空量成交97.1万股,卖空比例为6.37%
市场透视 · 07-04
每日卖空追踪 | 远大医药 07月04日卖空量成交97.1万股,卖空比例为6.37%
远大医药07月03日主力净流入206.7万元 散户资金抛售
市场透视 · 07-03
远大医药07月03日主力净流入206.7万元 散户资金抛售
每日卖空追踪 | 远大医药 07月02日卖空量成交122.3万股,卖空比例为5.82%
市场透视 · 07-02
每日卖空追踪 | 远大医药 07月02日卖空量成交122.3万股,卖空比例为5.82%
每日卖空追踪 | 远大医药 06月30日卖空量成交54.25万股,卖空比例为4.33%
市场透视 · 06-30
每日卖空追踪 | 远大医药 06月30日卖空量成交54.25万股,卖空比例为4.33%
加载更多
公司概况
公司名称:
远大医药
所属市场:
SEHK
上市日期:
--
主营业务:
远大医药健康控股有限公司是一家主要从事制造及销售医药制剂及医疗器械的香港投资控股公司。该公司主要从事制造及销售医药制剂及医疗器械、生物技术产品及营养产品、精品原料药和其他产品。该公司的主要产品涵盖抗肿瘤、心血管急救制剂及高端心脑血管介入医疗器械、抗病毒抗感染、呼吸及五官科以及生物健康产品和精品原料药。
发行价格:
--
{"stockData":{"symbol":"00512","market":"HK","secType":"STK","nameCN":"远大医药","latestPrice":9.27,"timestamp":1752221283024,"preClose":9.32,"halted":0,"volume":16014000,"delay":0,"floatShares":3549571148,"shares":3549571148,"eps":0.704885,"marketStatus":"未开盘","change":-0.05,"latestTime":"07-11 16:08:03","open":9.39,"high":9.55,"low":9.18,"amount":149437188,"amplitude":0.0397,"askPrice":9.28,"askSize":13000,"bidPrice":9.27,"bidSize":26000,"shortable":3,"etf":0,"ttmEps":0.704885,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752456600000},"marketStatusCode":0,"adr":0,"listingDate":819302400000,"exchange":"SEHK","adjPreClose":9.32,"dividendRate":0.028047,"openAndCloseTimeList":[[1752197400000,1752206400000],[1752210000000,1752220800000]],"volumeRatio":0.857551367940166,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00512","defaultTab":"news","newsList":[{"id":"2551777946","title":"创纪录!远大医药(00512)易甘泰®钇[90Y]15项研究成果入选顶级肝癌会议APPLE ,40万肝癌患者迎新希望","url":"https://stock-news.laohu8.com/highlight/detail?id=2551777946","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551777946?lang=zh_cn&edition=full","pubTime":"2025-07-13 17:20","pubTimestamp":1752398438,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,易甘泰钇[90Y]微球注射液自2022年在中国大陆上市以来,至今已惠及超3000例肝部肿瘤患者。这一里程碑式的突破,或将加速易甘泰的国内商业化,并全面重塑中国肝癌的治疗格局。APPLE大会自首届在韩国举办以来,十余年间已发展成为备受瞩目的亚太地区肝癌领域顶级学术盛会。惠及我国每年近40万新增患者,易甘泰或重塑肝癌治疗格局根据GLOBOCAN 2022年的数据,肝癌全球新发病例约87万,位居肿瘤第六位;死亡病例约76万,居第三位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1317073.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0187","BK0012","BK0183","00512","BK1191","BK0196","BK0238","000876","BK0188"],"gpt_icon":0},{"id":"2550595511","title":"晚讯|AI+生物制造风口!9个涉及蛋白质设计案例获国家级认可!FDA获批、国产核药创“全球首个”,能否趁势崛起?","url":"https://stock-news.laohu8.com/highlight/detail?id=2550595511","media":"生物谷","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550595511?lang=zh_cn&edition=full","pubTime":"2025-07-11 19:58","pubTimestamp":1752235135,"startTime":"0","endTime":"0","summary":"16个案例中9个涉及高性能蛋白质元件设计及构建,显示AI+生物制造趋势。欧盟旨在2030年成为最具吸引力生命科学区,发酵行业可推动医药、食品等创新,支持就业及经济增长。同时提出《生物技术法案》加快新产品审批,创建AI工具应对监管环境,加快新型食品上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711203845a444e382&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711203845a444e382&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRK","BK1191","00512"],"gpt_icon":0},{"id":"2550993572","title":"每日卖空追踪 | 远大医药 07月11日卖空量成交49.75万股,卖空比例为3.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550993572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550993572?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:30","pubTimestamp":1752222614,"startTime":"0","endTime":"0","summary":"远大医药北京时间07月11日,跌0.54%,卖空量成交49.75万股%,较上一交易日减少79.53%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711172020a6a37afe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711172020a6a37afe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2550933877","title":"远大医药07月11日遭主力抛售179.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550933877","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550933877?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:15","pubTimestamp":1752221736,"startTime":"0","endTime":"0","summary":"07月11日, 远大医药股价跌0.54%,报收9.27元,成交金额1.5亿元,换手率0.45%,振幅3.97%,量比0.85。远大医药今日主力资金净流出179.1万元,上一交易日主力净流出486.6万元。该股近5个交易日下跌2.74%,主力资金累计净流入714.8万元;近20日主力资金累计净流出5614.1万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711170056a6a36d55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711170056a6a36d55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2550961209","title":"远大医药07月10日主力净流出486.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2550961209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550961209?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:15","pubTimestamp":1752135334,"startTime":"0","endTime":"0","summary":"07月10日, 远大医药股价跌2.20%,报收9.32元,成交金额1.5亿元,换手率0.43%,振幅4.51%,量比0.76。远大医药今日主力资金净流出486.6万元,上一交易日主力净流入610.7万元。该股近5个交易日上涨1.30%,主力资金累计净流入2181.9万元;近20日主力资金累计净流出4737.6万元,其中净流出天数为10日。该股主力净额占比0.01%,港股市场排名2423/2673。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710165420a4422e81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710165420a4422e81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2550168068","title":"每日卖空追踪 | 远大医药 07月09日卖空量成交243万股,卖空比例为13.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550168068","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550168068?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:30","pubTimestamp":1752049814,"startTime":"0","endTime":"0","summary":"远大医药北京时间07月09日,涨1.38%,卖空量成交243万股%,较上一交易日减少45.9%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709171906a69f1658&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709171906a69f1658&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2550682290","title":"远大医药07月09日获主力加仓610.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550682290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550682290?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:15","pubTimestamp":1752048915,"startTime":"0","endTime":"0","summary":"07月09日, 远大医药股价涨1.38%,报收9.53元,成交金额1.7亿元,换手率0.50%,振幅5.43%,量比0.85。远大医药今日主力资金净流入610.7万元,上一交易日主力净流入794.1万元。该股近5个交易日上涨6.59%,主力资金累计净流入2875.2万元;近20日主力资金累计净流出5689.3万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709165107a69f03c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709165107a69f03c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2550050421","title":"FDA提前批准!远大医药核药再创全球首个","url":"https://stock-news.laohu8.com/highlight/detail?id=2550050421","media":"瞪羚社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550050421?lang=zh_cn&edition=full","pubTime":"2025-07-08 20:26","pubTimestamp":1751977560,"startTime":"0","endTime":"0","summary":"此次提前批准是基于DOORwaY90研究的突破性中期数据成功达到预设主要终点,且未限制肿瘤直径大小,由此易甘泰成为全球首个且唯一获FDA批准用于不可切除HCC和结直肠癌肝转移双重适应症的选择性内放射治疗产品。从稀缺性可见,能够获得FDA加速批准的产品皆具备开创性和卓越的疗效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709124842953bb50c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709124842953bb50c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2549056025","title":"创新药概念股多数走强 恒瑞医药(01276)涨3.37% 机构称创新药产业投资趋势明确","url":"https://stock-news.laohu8.com/highlight/detail?id=2549056025","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549056025?lang=zh_cn&edition=full","pubTime":"2025-07-08 09:54","pubTimestamp":1751939650,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念股多数走强,截至发稿,恒瑞医药 涨3.37%,远大医药涨3.13%,四环医药涨2.80%,博安生物涨2.45%,华昊中天医药-B涨2.38%,乐普生物-B涨2.31%。消息面上,中金公司发研报指,创新药产业投资趋势明确,向上传导或有产业链机会。同时,一二级融资的便利,国际形势趋缓带来产业链CXO/科研上游等领域的衍生投资机会。","market":"other","thumbnail":"https://static.szfiu.com/news/20210810/NTRmYzVmNDdmYzg0MjRhYWE5NzljZDI3ZDUxMDYzNjE2NzY4MDQ=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NTRmYzVmNDdmYzg0MjRhYWE5NzljZDI3ZDUxMDYzNjE2NzY4MDQ=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1961802","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK0012","LU0405327148.USD","LU1064130708.USD","06955","BK0196","BK0239","LU1969619763.USD","LU1064131003.USD","BK1515","06978","LU2148510915.USD","LU1997245177.USD","LU2495084118.USD","BK1600","02563","02157","BK1574","LU1997244956.HKD","LU1328615791.USD","BK0060","LU2488822045.USD","BK1593","600276","00512","LU2328871848.SGD","159992","00460","LU1997245094.SGD","BK1191","BK0028","LU1655091616.SGD","LU0405327494.USD","BK0183","BK0188","01276"],"gpt_icon":0},{"id":"2549983635","title":"远大医药:高开5.5%,易甘泰获FDA提前批准新适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2549983635","media":"和讯网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549983635?lang=zh_cn&edition=full","pubTime":"2025-07-08 09:51","pubTimestamp":1751939505,"startTime":"0","endTime":"0","summary":"7月8日,远大医药高开5.5%,报9.78港元。消息显示,远大医药易甘泰近日获FDA提前正式批准新增HCC适应症,成全球唯一FDA批准双适应症SIRT产品。昨晚,远大医药公告,基于钇[90Y]微球注射液DOORwaY90临床试验突破性中期数据达预设共同主要终点,FDA提前正式批准该产品新增治疗不可切除肝细胞癌适应症,且未限制肿瘤直径大小。本文由 AI 算法生成,仅作参考,不涉投资建议,使用风险自担","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708100348953a3d21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708100348953a3d21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2549662562","title":"港股异动 | 远大医药(00512)高开逾5% 易甘泰获FDA提前正式批准新增HCC适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2549662562","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549662562?lang=zh_cn&edition=full","pubTime":"2025-07-08 09:23","pubTimestamp":1751937825,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,远大医药高开逾5%,截至发稿,涨5.5%,报9.78港元,成交额636.19万港元。消息面上,远大医药公告,基于钇[90Y]微球注射液DOORwaY90临床试验的突破性中期数据成功达到预设的共同主要终点,FDA提前正式批准了该产品新增适应症,用于治疗不可切除肝细胞癌,且未限制肿瘤直径大小。这标志着SIR-Spheres钇[90Y]微球注射液成为了全球首个且唯一获FDA批准用于不可切除HCC和结直肠癌肝转移双重适应症的选择性内放射治疗产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1314953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00512","HCC","BK4006"],"gpt_icon":0},{"id":"2549559132","title":"全球核药龙头大消息","url":"https://stock-news.laohu8.com/highlight/detail?id=2549559132","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549559132?lang=zh_cn&edition=full","pubTime":"2025-07-08 00:03","pubTimestamp":1751904214,"startTime":"0","endTime":"0","summary":"全球核药龙头大消息!在全球结直肠癌肝转移选择性内放射治疗领域大放异彩后,全球核药龙头远大医药的全球创新核药SIR-Spheres钇[90Y]微球注射液(易甘泰),近期又打开了肝细胞癌治疗的大门。这表明,远大医药的海外临床注册能力已跻身全球领先水平,将为其后续自研创新核药产品的海外开发工作奠定重要基础。根据GLOBOCAN 2022年的数据,肝癌是全球第六大新发癌症以及第三大致死癌症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708000959a43c2b60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708000959a43c2b60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2549397530","title":"远大医药(00512)易甘泰®海外临床取得突破性中期数据,获FDA提前正式批准拓展HCC适应症,或重塑肝癌治疗格局","url":"https://stock-news.laohu8.com/highlight/detail?id=2549397530","media":"智通财经","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549397530?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:12","pubTimestamp":1751893977,"startTime":"0","endTime":"0","summary":"中国药企核药海外研发迎来里程碑时刻——远大医药全球创新核药SIR-Spheres钇[90Y]微球注射液(易甘泰)继在全球结直肠癌肝转移选择性内放射治疗领域大放异彩后,该产品近期又打开了肝细胞癌治疗的大门。基于上述突破性中期临床数据,FDA提前正式批准了该产品用于不可切除HCC的适应症,且未限制肿瘤直径大小。根据GLOBOCAN 2022年的数据,肝癌是全球第六大新发癌症以及第三大致死癌症。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1314846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00512","HCC","BK1191","BK4006"],"gpt_icon":0},{"id":"2549453772","title":"远大医药(00512.HK):集团全球创新放射性产品SIR-Spheres®钇[90Y]微球注射液提前正式获得FDA批准新增适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2549453772","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549453772?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:09","pubTimestamp":1751893752,"startTime":"0","endTime":"0","summary":"格隆汇7月7日丨远大医药公告,集团联营公司Sirtex Medical Pty Ltd的SIR-Spheres钇[90Y]微球注射液近日获得美国食品药品监督管理局正式批准新增适应症,用于治疗不可切除肝细胞癌。集团始终重视研发创新,依托核药全球化布局及自主可控的产业生态,已构建覆盖诊断治疗一体化、国内国际双循环的核医学创新矩阵,形成\"研发-生产-销售\"全产业链闭环体系。未来,集团将持续推进核药抗肿瘤诊疗产品的全球拓展及商业化进程,巩固全球行业领先地位。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/07210951538330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["00512","SIR","BK1191"],"gpt_icon":0},{"id":"2549587112","title":"每日卖空追踪 | 远大医药 07月07日卖空量成交125.1万股,卖空比例为10.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549587112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549587112?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:30","pubTimestamp":1751877014,"startTime":"0","endTime":"0","summary":"远大医药北京时间07月07日,跌2.42%,卖空量成交125.1万股%,较上一交易日减少59.54%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707171442a69aa74f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707171442a69aa74f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2549828335","title":"远大医药07月07日主力净流出24.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2549828335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549828335?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:15","pubTimestamp":1751876140,"startTime":"0","endTime":"0","summary":"07月07日, 远大医药股价跌2.42%,报收9.27元,成交金额1.1亿元,换手率0.34%,振幅4.53%,量比0.71。远大医药今日主力资金净流出24.2万元,上一交易日主力净流入1288.0万元。该股近5个交易日上涨7.76%,主力资金累计净流入645.0万元;近20日主力资金累计净流出1464.5万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707165644a69a9ba0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707165644a69a9ba0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2548198364","title":"每日卖空追踪 | 远大医药 07月04日卖空量成交97.1万股,卖空比例为6.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548198364","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548198364?lang=zh_cn&edition=full","pubTime":"2025-07-04 16:30","pubTimestamp":1751617814,"startTime":"0","endTime":"0","summary":"远大医药北京时间07月04日,涨3.15%,卖空量成交97.1万股%,较上一交易日减少74.84%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704171745a4369cb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704171745a4369cb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2548870273","title":"远大医药07月03日主力净流入206.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2548870273","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548870273?lang=zh_cn&edition=full","pubTime":"2025-07-03 16:15","pubTimestamp":1751530559,"startTime":"0","endTime":"0","summary":"07月03日, 远大医药股价涨2.91%,报收9.21元,成交金额2.1亿元,换手率0.65%,振幅4.58%,量比1.38。远大医药今日主力资金净流入206.7万元,上一交易日主力净流出775.0万元。该股近5个交易日上涨4.55%,主力资金累计净流入944.0万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出3773.7万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703171020a4cd0020&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703171020a4cd0020&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2548867889","title":"每日卖空追踪 | 远大医药 07月02日卖空量成交122.3万股,卖空比例为5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548867889","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548867889?lang=zh_cn&edition=full","pubTime":"2025-07-02 16:30","pubTimestamp":1751445014,"startTime":"0","endTime":"0","summary":"远大医药北京时间07月02日,涨2.64%,卖空量成交122.3万股%,较上一交易日减少11.86%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702171609a4cadac2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702171609a4cadac2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2547061100","title":"每日卖空追踪 | 远大医药 06月30日卖空量成交54.25万股,卖空比例为4.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547061100","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547061100?lang=zh_cn&edition=full","pubTime":"2025-06-30 16:30","pubTimestamp":1751272212,"startTime":"0","endTime":"0","summary":"远大医药北京时间06月30日,涨1.04%,卖空量成交54.25万股%,较上一交易日减少56.13%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630171357a725c0eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630171357a725c0eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinagrandpharm.com","stockEarnings":[{"period":"1week","weight":-0.0242},{"period":"1month","weight":0.0022},{"period":"3month","weight":0.6407},{"period":"6month","weight":1.1889},{"period":"1year","weight":1.0329},{"period":"ytd","weight":1.02}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":-0.0093},{"period":"3month","weight":0.1542},{"period":"6month","weight":0.2662},{"period":"1year","weight":0.3537},{"period":"ytd","weight":0.2034}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"远大医药健康控股有限公司是一家主要从事制造及销售医药制剂及医疗器械的香港投资控股公司。该公司主要从事制造及销售医药制剂及医疗器械、生物技术产品及营养产品、精品原料药和其他产品。该公司的主要产品涵盖抗肿瘤、心血管急救制剂及高端心脑血管介入医疗器械、抗病毒抗感染、呼吸及五官科以及生物健康产品和精品原料药。","yearOnYearQuotes":[{"month":1,"riseRate":0.466667,"avgChangeRate":0.087032},{"month":2,"riseRate":0.7,"avgChangeRate":0.108479},{"month":3,"riseRate":0.4,"avgChangeRate":0.019078},{"month":4,"riseRate":0.633333,"avgChangeRate":0.018767},{"month":5,"riseRate":0.466667,"avgChangeRate":0.084333},{"month":6,"riseRate":0.366667,"avgChangeRate":-0.048262},{"month":7,"riseRate":0.4,"avgChangeRate":-0.013688},{"month":8,"riseRate":0.37931,"avgChangeRate":0.004561},{"month":9,"riseRate":0.482759,"avgChangeRate":-0.037401},{"month":10,"riseRate":0.517241,"avgChangeRate":-0.014293},{"month":11,"riseRate":0.517241,"avgChangeRate":0.088816},{"month":12,"riseRate":0.517241,"avgChangeRate":-0.006306}],"exchange":"SEHK","name":"远大医药","nameEN":"GRAND PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"远大医药(00512)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供远大医药(00512)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"远大医药,00512,远大医药股票,远大医药股票老虎,远大医药股票老虎国际,远大医药行情,远大医药股票行情,远大医药股价,远大医药股市,远大医药股票价格,远大医药股票交易,远大医药股票购买,远大医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"远大医药(00512)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供远大医药(00512)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}